Join
Live feed
·
INSIDERFilingvia Quantisnow
Codiak BioSciences Inc. logo

SEC Form 4: Melas Kyriazi Theo converted options into 8,750 shares, increasing direct ownership by 133% to 15,350 units

ByQuantisnow·Wall Street's wire, on your screen.
CDAK· Codiak BioSciences Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CDAK (Codiak BioSciences Inc.) and more on Quantisnow.